Anthony D. Anderson

506 total citations
32 papers, 249 citations indexed

About

Anthony D. Anderson is a scholar working on Epidemiology, Oncology and Infectious Diseases. According to data from OpenAlex, Anthony D. Anderson has authored 32 papers receiving a total of 249 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 13 papers in Oncology and 11 papers in Infectious Diseases. Recurrent topics in Anthony D. Anderson's work include Cytomegalovirus and herpesvirus research (8 papers), Antifungal resistance and susceptibility (7 papers) and Hematopoietic Stem Cell Transplantation (6 papers). Anthony D. Anderson is often cited by papers focused on Cytomegalovirus and herpesvirus research (8 papers), Antifungal resistance and susceptibility (7 papers) and Hematopoietic Stem Cell Transplantation (6 papers). Anthony D. Anderson collaborates with scholars based in United States. Anthony D. Anderson's co-authors include José F. Camargo, Krishna V. Komanduri, Michele I. Morris, Mohammed Raja, Miranda Andrus, Yoichiro Natori, Lazaros J. Lekakis, Dayna McManus, Trent Wang and Denise Pereira and has published in prestigious journals such as Blood, Energy & Environmental Science and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Anthony D. Anderson

30 papers receiving 243 citations

Peers

Countries citing papers authored by Anthony D. Anderson

Since Specialization

Citations

This map shows the geographic impact of Anthony D. Anderson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony D. Anderson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony D. Anderson more than expected).

Fields of papers citing papers by Anthony D. Anderson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony D. Anderson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony D. Anderson. The network helps show where Anthony D. Anderson may publish in the future.

Co-authorship network of co-authors of Anthony D. Anderson

This figure shows the co-authorship network connecting the top 25 collaborators of Anthony D. Anderson. A scholar is included among the top collaborators of Anthony D. Anderson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony D. Anderson. Anthony D. Anderson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Possible increased risk of Epstein–Barr virus (EBV) infection and post-transplant lymphoproliferative disease (PTLD) in letermovir-exposed haematopoietic cell transplantation recipients 2025 ·Journal of Antimicrobial Chemotherapy ·José F. Camargo, (unknown), Anthony D. Anderson	0
2	“What am I?” microbiology of culture-positive, biofire® blood culture identification 2 panel-negative bloodstream infections 2025 ·Diagnostic Microbiology and Infectious Disease ·Joseph R. Berger, Divya Pandya, (unknown), Octavio Martínez, Anthony D. Anderson, José F. Camargo	1
3	Incidence and outcomes of cytomegalovirus reactivation after chimeric antigen receptor T-cell therapy 2024 ·Blood Advances ·(unknown), Anthony D. Anderson, Yoichiro Natori, Mohammed Raja, Michele I. Morris, Antonio Jiménez, Amer Beitinjaneh, Trent Wang, Mark Goodman, Lazaros J. Lekakis, Jay Y. Spiegel, Noa G. Holtzman, Denise Pereira, Cara L. Benjamin, Akina Natori, Krishna V. Komanduri, José F. Camargo	12
4	The painful blue hurt: a rare limb- and life-threatening condition 2024 ·The American Journal of the Medical Sciences ·(unknown), Anthony D. Anderson, (unknown), P. Aiden McCormick, (unknown), Stephen P. Kantrow	0
5	Successful restoration of protective immunity against measles, mumps, and rubella following MMR vaccination in adult hematopoietic cell transplant recipients 2023 ·Transplant Infectious Disease ·(unknown), Anthony D. Anderson, Michele I. Morris, Mohammed Raja, Krishna V. Komanduri, José F. Camargo	3
6	Breakthrough invasive fungal infections on isavuconazole prophylaxis in hematologic malignancy & hematopoietic stem cell transplant patients 2023 ·Transplant Infectious Disease ·Akshay Khatri, Yoichiro Natori, Anthony D. Anderson, (unknown), Shreya Shah, Akina Natori, Namrata S. Chandhok, Krishna V. Komanduri, Michele I. Morris, José F. Camargo, Mohammed Raja	7
7	Early administration of SARS‐CoV‐2 monoclonal antibody reduces the risk of mortality in hematologic malignancy and hematopoietic cell transplant patients with COVID‐19 2023 ·Transplant Infectious Disease ·(unknown), Akshay Khatri, Anthony D. Anderson, (unknown), (unknown), Yoichiro Natori, Mohammed Raja, José F. Camargo, Michele I. Morris	3
8	Incidence and Outcomes of Cytomegalovirus Reactivation after Chimeric Antigen Receptor T Cell Therapy 2023 ·Blood ·(unknown), Anthony D. Anderson, Mohammed Raja, Michele I. Morris, Antonio Jiménez, Amer Beitinjaneh, Trent Wang, Mark Goodman, Lazaros J. Lekakis, Jay Y. Spiegel, Denise Pereira, Krishna V. Komanduri, José F. Camargo	3
9	Invasive Aspergillosis Remains Associated with High Mortality in Hematopoietic Transplant Recipients in the Current Era 2021 ·Transplantation and Cellular Therapy ·José Francisco Suárez, Maria A. Mendoza, Anthony D. Anderson, (unknown), Michele I. Morris, Yoichiro Natori, Mohammed Raja, Lazaros J. Lekakis, Amer Beitinjaneh, Antonio Jiménez, (unknown), Trent Wang, Denise Pereira, Krishna V. Komanduri, José F. Camargo	1
10	Clinical Presentation and Outcomes of COVID-19 Following Hematopoietic Cell Transplantation 2021 ·Transplantation and Cellular Therapy ·José F. Camargo, Maria A. Mendoza, (unknown), (unknown), Anthony D. Anderson, Michele I. Morris, Yoichiro Natori, Mohammed Raja, Lazaros J. Lekakis, Amer Beitinjaneh, Antonio Jiménez, (unknown), Trent Wang, Krishna V. Komanduri, (unknown)	1
11	Lower Incidence of Cytomegalovirus Reactivation Following Post-Transplantation Cyclophosphamide HLA-Mismatched Unrelated Donor Transplantation 2021 ·Transplantation and Cellular Therapy ·José F. Camargo, (unknown), (unknown), Yoichiro Natori, (unknown), Michele I. Morris, (unknown), Anthony D. Anderson, Lazaros J. Lekakis, Amer Beitinjaneh, Mark Goodman, Trent Wang, Denise Pereira, Krishna V. Komanduri	5
12	Viral kinetics and outcomes of adenovirus viremia following allogeneic hematopoietic cell transplantation 2021 ·Clinical Transplantation ·(unknown), Anthony D. Anderson, Michele I. Morris, Yoichiro Natori, Antonio Jiménez, Krishna V. Komanduri, José F. Camargo	2
13	Clinical presentation and outcomes of COVID‐19 following hematopoietic cell transplantation and cellular therapy 2021 ·Transplant Infectious Disease ·José F. Camargo, Maria A. Mendoza, (unknown), (unknown), Anthony D. Anderson, (unknown), Yoichiro Natori, Akina Natori, Mohammed Raja, Lazaros J. Lekakis, Amer Beitinjaneh, Antonio Jiménez, Mark Goodman, Trent Wang, Krishna V. Komanduri, Denise Pereira	19
14	Clinical “real‐world” experience with letermovir for prevention of cytomegalovirus infection in allogeneic hematopoietic cell transplant recipients 2020 ·Clinical Transplantation ·Anthony D. Anderson, Mohammed Raja, (unknown), Michele I. Morris, Krishna V. Komanduri, José F. Camargo	53
15	Reduced immunogenicity of the adjuvanted recombinant zoster vaccine after hematopoietic cell transplant: a pilot study 2020 ·Blood Advances ·José F. Camargo, (unknown), Yoichiro Natori, Anthony D. Anderson, (unknown), Trent Wang, Michele I. Morris, Krishna V. Komanduri	13
16	Successful Treatment of Invasive Fungal Infection Due to Highly Resistant Aspergillus calidoustus in an Allogeneic Hematopoietic Cell Transplant Recipient 2020 ·Mycopathologia ·Maria A. Mendoza, Anthony D. Anderson, Michele I. Morris, Lazaros J. Lekakis, Jacques Simkins, (unknown), Octavio Martínez, Krishna V. Komanduri, José F. Camargo	8
17	Achievement of clinical isavuconazole blood concentrations in transplant recipients with isavuconazonium sulphate capsules administered via enteral feeding tube 2020 ·Journal of Antimicrobial Chemotherapy ·Erin K. McCreary, M. Hong Nguyen, Matthew R Davis, (unknown), Ryan K. Shields, Anthony D. Anderson, Ryan Rivosecchi, Rachel V Marini, (unknown), Fernanda P. Silveira, David R. Andes, Alexander J. Lepak	14
18	Use of maintenance therapy and incidence of recurrent Cytomegalovirus DNAemia among allogeneic hematopoietic cell transplant recipients 2019 ·Transplant Infectious Disease ·José F. Camargo, Anthony D. Anderson, Rossana Rosa, Erik L. Kimble, Krishna V. Komanduri, Michele I. Morris	4
19	Failure of atovaquone prophylaxis for prevention of toxoplasmosis in hematopoietic cell transplant recipients 2019 ·Transplant Infectious Disease ·(unknown), (unknown), Anthony D. Anderson, Michele I. Morris, Krishna V. Komanduri, José F. Camargo	8
20	A retrospective review of student pharmacist medication reconciliation activities in an outpatient family medicine center 2015 ·Pharmacy Practice ·Miranda Andrus, Anthony D. Anderson	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact